The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats

REFERENCES

• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.
   PubMed Web of Science ®Google Scholar
• Copple BL, Jaeschke H, Klaassen CD. Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis. 2010;30:195–204.
   PubMed Web of Science ®Google Scholar
• Feldmeier J. Hyperbaric Oxygen 2003: Indications and Results. The Hyperbaric Oxygen Committee Report. Flagstaff, AZ: Undersea and Hyperbaric Medicine Society, 2003.
   Google Scholar
• Ayvaz S, Kanter M, Aksu B, et al. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats. J Surg Res. 2013;183:146–155.
   PubMed Web of Science ®Google Scholar
• Idetsu A, Suehiro T, Okada K, et al. Hyperbaric oxygenation promotes regeneration of biliary cells and improves cholestasis in rats. World J Gastroenterol. 2011;17:2229–2235.
   PubMed Web of Science ®Google Scholar
• Castro e Silva O, Sankarankutty AK, Martinelli AL, et al. Therapeutic effect of hyperbaric oxygen in hepatic artery thrombosis and functional cholestasis after orthotopic liver transplantation. Transplant Proc. 2006;38:1913–1917.
   PubMed Web of Science ®Google Scholar
• Oter S, Edremitlioglu M, Korkmaz A, et al. Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med. 2005;31:1262–1268.
   PubMed Web of Science ®Google Scholar
• Yu SY, Chiu JH, Yang SD, et al. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J Surg Res. 2005;128:28–36.
   PubMed Web of Science ®Google Scholar
• Ozden TA, Uzun H, Bohloli M, et al. The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med. 2004;203:253–265.
   PubMed Web of Science ®Google Scholar
• Tram TH, Miller JCB, McNeil Y, et al. Sialic acid content of infant saliva: comparison of breast-fed with formula fed infants. Arch Dis Child. 1997;77:315–318.
   PubMed Web of Science ®Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357–363.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Ozcan O, Gultepe M, Ipcioglu OM, et al. Optimization of the photometric enzyme activity assay for evaluating real activity of prolidase. Turkish J Biochem. 2007;32:12–16.
   Google Scholar
• Benzie IFF, Strain II. The reducing ability of plasma as a measure of antioxidant power—the FRAP assay. Anal Biochem. 1996;239:70–76.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hong JY, Rockwell CE, et al. Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int. 2012;32:58–69.
   PubMed Web of Science ®Google Scholar
• Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol. 1997;17:549–562.
   PubMed Web of Science ®Google Scholar
• Colette CP, Prosser CC, Yen RD, et al. Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol. 2006;12:509–515.
   PubMed Web of Science ®Google Scholar
• Fedorova M, Bollineni RC, Hoffmann R. Proteın carbonylatıon as a major hallmark of oxıdatıve damage: update of analytıcal strategıes. Mass Spectrom Rev. 2014;33:79–97.
   PubMed Web of Science ®Google Scholar
• Sundari PN, Wilfred G, Ramakrishna B. Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat? Biochim Biophys Acta 1997;1362:169–176.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23–38.
   PubMed Web of Science ®Google Scholar
• Pisoschi AM, Negulescu GP. Methods for total antioxidant activity determination: a review. Pisoschi Negulescu Biochem Anal Biochem. 2011;1:106.
   Google Scholar
• Nagamine K, Kubota T, Togo S, et al. Beneficial effect of hyperbaric oxygen therapy on liver regeneration after 90% hepatectomy in rats. Eur Surg Res. 2004;36:350–356.
   PubMed Web of Science ®Google Scholar
• Tsuneyama K, Chen YC, Fujimoto M, et al. Advantages and disadvantages of hyperbaric oxygen treatment in mice with obesity hyperlipidemia and steatohepatitis. Scientific World J. 2011;11:2124–2135.
   Web of Science ®Google Scholar
• Thom SR. Hyperbaric oxygen therapy. J Intensive Care Med. 1989;4:58–74.
   Google Scholar
• Brosset B, Myara I, Fabre M, et al. Plasma prolidase and prolinase activity in alcoholic liver disease. Clin Chim Acta 1988;175:291–295.
   PubMed Web of Science ®Google Scholar
• Myara I, Myara A, Mangeot M, et al. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem. 1984;30:211–215.
   PubMed Web of Science ®Google Scholar
• Abraham P, Wilfred G, Ramakrishna B. Plasma prolidase may be an index of liver fibrosis in the rat. Clin Chim Acta 2000;295:199–202.
   PubMed Web of Science ®Google Scholar
• Tarçin O, Avşar K, Demirtürk L, et al. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity. J Gastroenterol Hepatol. 2003;18:437–444.
   PubMed Web of Science ®Google Scholar
• Evrenkaya TR, Atasoyu EM, Kara M, et al. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail. 2006;28:271–274.
   PubMed Web of Science ®Google Scholar
• Aslan M, Nazligul Y, Horoz M, et al. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem. 2007;40:37–40.
   PubMed Web of Science ®Google Scholar
• Cakmak A, Zeyrek D, Atas A, et al. Serum prolidase activity and oxidative status in patients with bronchial asthma. J Clin Lab Anal. 2009;23:132–138.
   PubMed Web of Science ®Google Scholar
• Toy H, Camuzcuoglu H, AriozDT, et al. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. J Obstet Gynaecol Res. 2009;35:1047–1053.
   PubMed Web of Science ®Google Scholar
• Demirbag R, Yildiz A, Gur M, et al. Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy. Clin Biochem. 2007;40:1020–1025.
   PubMed Web of Science ®Google Scholar
• Erbagci AB, Araz M, Erbagci A, et al. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem. 2002;35:263–268.
   PubMed Web of Science ®Google Scholar
• Kayadibi H, Gultepe M, Yasar B, et al. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. Dig Dis Sci. 2009;54:1764–1771.
   PubMed Web of Science ®Google Scholar
• Stanfliet JC, Locketz M, Berman P, et al. Evaluation of the utility of serum prolidase as a marker for liver fibrosis. J Clin Lab Anal. 2015;29:208–213.
   PubMed Web of Science ®Google Scholar
• Hopf HW, Gibson JJ, Angeles AP, et al. Hyperoxia and angiogenesis. Wound Repair Regen. 2005;13:558–564.
   PubMed Web of Science ®Google Scholar
• Dinar S, Agir H, Sen C, et al. Effects of hyperbaric oxygen therapy on fibrovascular ingrowth in porous polyethylene blocks implanted under burn scar tissue: an experimental study. Burns 2008;34:467–473.
   PubMed Web of Science ®Google Scholar
• Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127(Suppl 1):131S–141S.
   PubMed Web of Science ®Google Scholar
• Powell LW, LaMont JT, Isselbacher KJ. Haemolysis in experimental cholestasis: possible role of erythrocyte sialic acid. Gut 1974;15:794–798.
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Itakura M, Iwamura K, et al. Serum sialic acid levels in liver cirrhosis and liver cancer. Nippon Shoka Kibyo Gakkari Zasshi 1981;78:2395–2401.
   PubMedGoogle Scholar
• Stefenelli N, Klotz H, Engel A, et al. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol. 1985;109:55–59.
   PubMed Web of Science ®Google Scholar
• Arif S, Haq N, Hanif R, et al. Variations of serum sialic acid level in liver cirrhosis. J Ayub Med Coll Abbottabad 2005;17:54–57.
   Google Scholar
• Cylwik B, Chrostek L, Panasiuk A, et al. Serum total and free sialic acid in patients with chronic liver disease. Clin Chem Lab Med. 2010;48:137–139.
   PubMed Web of Science ®Google Scholar